Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Survodutide (also designated BI 456906) is a synthetic peptide developed by Boehringer Ingelheim that activates two receptors simultaneously: the GLP-1 receptor and the glucagon receptor
For GLP-1 users aiming to lose weight without sacrificing muscle mass, a BCL6-boosting injectable might become available in the future
Clinical trial data reviewed by the U.S
AI health coach, 24/7: Knows your labs, trends, and protocol, so support is available the moment a question or side effect comes up
Clinical trial number NCT03574597 for "Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity (SELECT)" at ClinicalTrials.gov
Muscle is metabolically active, which means it expends energy even when at rest
US$ 20.50
US$ 25.16
US$ 20.86
US$ 26.79
